Financials
Half-year Report | Sep. 27, 2024 |
Final Results | Apr. 25, 2024 |
Half-year Report | Sep. 28, 2023 |
Final Results for the Year Ended 31 December 2022 | Apr. 28, 2023 |
Half-year Report | Sep. 29, 2022 |
Annual Report & Financial Statements for the Year Ended 31 December 2021 | Apr. 29, 2022 |
Annual Report & Financial Statements for the Year Ended 31 December 2021 | Apr. 29, 2022 |
Proxies
Result of Annual General Meeting | Jun. 27, 2024 |
Posting of Annual Report & Notice of AGM | Jun. 03, 2024 |
Result of Annual General Meeting | Jun. 30, 2023 |
Resolutions passed at Annual General Meeting of Hemogenyx Pharmaceuticals plc on 30 June 2023 | Jun. 30, 2023 |
Posting of Annual Report & Notice of AGM | Jun. 02, 2023 |
Resolutions passed at Annual General Meeting of Hemogenyx Pharmaceuticals plc on 30 June 2022 | Jun. 30, 2022 |
Result of Annual General Meeting | Jun. 30, 2022 |
Ownership Update
Director/PDMR Shareholding | May. 30, 2022 |
Holding(s) in Company | May. 27, 2021 |
Holding(s) in Company | May. 27, 2021 |
Director/PDMR Shareholding | May. 19, 2021 |
Director/PDMR Shareholding | Mar. 09, 2021 |
Further re. Grant of Options | Sep. 22, 2020 |
Grant of Options | Aug. 21, 2020 |
Announcements
Total Voting Rights | Jan. 31, 2025 |
Placing to raise £340,000 | Jan. 08, 2025 |
Change of Company Secretary and Registered Office | Jan. 02, 2025 |
Total Voting Rights | Dec. 31, 2024 |
Opening of First Clinical Site | Dec. 30, 2024 |
Admission of New Ordinary Shares and New ISIN | Dec. 10, 2024 |
Result of Extraordinary General Meeting | Dec. 09, 2024 |
Prospectuses
Prospectus | Jan. 29, 2021 |
Hemogenyx Pharmaceuticals Plc - Single prospectus | Jan. 29, 2021 |
Financing Facility of up to £60 Million | Nov. 18, 2020 |
Prospectus | Sep. 11, 2017 |
Prospectus relating to the placing of 43,300,000 New Ordinary shares of £0. | Nov. 03, 2015 |